Registrieren

Registierung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting | The Manila Times

Highlights FORTIFY, the Phase 1b indication expansion trial of PLN-101095 

Ähnliche Seiten

https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/autolus-therapeutics-to-present-clinical-data-update-at-the-american-society-of-clinical-oncology-annual-meeting-2026/2349713

Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026 | The Manila Times

https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/autolus-therapeutics-to-present-clinical-data-update-at-the-american-society-of-clinical-oncology-annual-meeting-2026/2349713
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/crescent-biopharma-announces-trial-in-progress-presentation-for-ascend-study-of-cr-001-a-pd-1-x-vegf-bispecific-antibody-at-upcoming-american-society-of-clinical-oncology-asco-2026-annual-meeting/2349723

Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting...

https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/crescent-biopharma-announces-trial-in-progress-presentation-for-ascend-study-of-cr-001-a-pd-1-x-vegf-bispecific-antibody-at-upcoming-american-society-of-clinical-oncology-asco-2026-annual-meeting/2349723
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/eikon-therapeutics-announces-availability-of-six-abstracts-for-presentation-at-the-2026-annual-meeting-of-the-american-society-of-clinical-oncology/2349709

Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology | The Manila Times

https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/eikon-therapeutics-announces-availability-of-six-abstracts-for-presentation-at-the-2026-annual-meeting-of-the-american-society-of-clinical-oncology/2349709
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/remix-therapeutics-announces-positive-data-from-phase-12-aria-study-of-first-in-class-myb-mrna-degrader-rem-422-in-patients-with-adenoid-cystic-carcinoma-acc-at-the-american-society-of-clinical-oncology-annual-meeting-2026/2349708

Remix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical ...

https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/remix-therapeutics-announces-positive-data-from-phase-12-aria-study-of-first-in-class-myb-mrna-degrader-rem-422-in-patients-with-adenoid-cystic-carcinoma-acc-at-the-american-society-of-clinical-oncology-annual-meeting-2026/2349708
https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/beyondspring-announces-poster-presentation-at-2026-asco-annual-meeting/2346086

BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting | The Manila Times

https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/beyondspring-announces-poster-presentation-at-2026-asco-annual-meeting/2346086
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/hutchmed-highlights-clinical-data-to-be-presented-at-the-2026-asco-annual-meeting/2349755

HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting | The Manila Times

https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/hutchmed-highlights-clinical-data-to-be-presented-at-the-2026-asco-annual-meeting/2349755